Uterine Carcinosarcoma
📧 Sign up to get email alerts when something new happens for Uterine Carcinosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is studying the combination of cabozantinib and dostarlimab for recurrent gynecologic carcinosarcoma, and recruit…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer [Phase 1, Phase 2]
Phase I/II study evaluating VLS-1488 in adults with advanced cancer; the trial is currently recruiting across multiple solid-tumor indicatio…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: A Study of HFB301001 in Adult Patients With Advanced Solid Tumors [Phase 1]
The Phase 1 trial of HFB301001 in adults with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone [Phase 2]
Phase 2 trial in recurrent or refractory endometrial cancer evaluating Olaparib with Durvalumab, Cediranib with Durvalumab, Olaparib with Ca…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) [Phase 2]
Phase 2 EndoBARR trial evaluating endometrial cancer with bevacizumab, atezolizumab, and rucaparib has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluates the combination of mirvetuximab soravtansine and rucaparib camsylate in patients with recurrent gynecologic cancer…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of Nivolumab in Selected Uterine Cancer Patients [Phase 2]
Phase 2 study of Nivolumab in selected uterine cancers has completed enrollment and posted results in 2024.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: ZW25 in Women With Endometrial Cancers [Phase 2]
Phase 2 trial of ZW25 in women with endometrial cancer and uterine carcinosarcoma has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary [Phase 1]
Phase 1 trial evaluating paclitaxel and carboplatin plus galunisertib in patients with uterine or ovarian carcinosarcoma has completed, with…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer [NA]
A terminated clinical trial evaluating radiation therapy with paclitaxel and carboplatin for various stages of uterine sarcoma/uteri neoplas…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer [Phase 2]
Phase 2 trial evaluating sunitinib malate in patients with recurrent or metastatic endometrial cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer [Phase 2]
Phase 2 trial updating the use of gemcitabine and docetaxel in recurrent or persistent uterine cancer, with results posted.
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating three regimens for endometrial cancer: paclitaxel-carboplatin-bevacizumab, paclitaxel-carboplatin-temsirolimus, and…
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer [Phase 2]
Phase 2 clinical trial evaluating pazopanib hydrochloride for recurrent or persistent uterine cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors [Phase 2]
Phase 2 multicenter study evaluating pegylated liposomal doxorubicin plus carboplatin in gynecologic mesenchymal tumors, including carcinosa…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer [Phase 2]
Phase 2 trial evaluating ixabepilone in patients with recurrent or persistent uterine cancer has completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus [Phase 2]
A Phase 2 trial of temsirolimus in patients with recurrent uterine sarcoma or uterine carcinosarcoma was terminated; results were posted in …
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus [Phase 2]
Phase 2 trial evaluating thalidomide for recurrent or persistent uterine carcinosarcoma shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer [Phase 2]
Phase 2 clinical trial evaluating imatinib mesylate in patients with recurrent or persistent uterine cancer has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating Ziv-aflibercept in locally advanced, unresectable, or metastatic gynecologic soft tissue sarcoma has completed with…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer [Phase 2]
Phase 2 trial of sorafenib in advanced or recurrent uterine cancer has completed and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of paclitaxel, carboplatin, and BSI-201 in advanced, persistent, or recurrent uterine ca…
-
CLINICAL_TRIALS trial_result · 2011-10-19Clinical Trial Update: A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma [Phase 1]
A Phase I trial evaluating lapatinib plus ixabepilone as second-line therapy for patients with HER-2 overexpressing recurrent or persistent …